A Delaware mother of four with a rare blood cancer says she feels "1,000% better" after joining an experimental trial combining two FDA-approved drugs.
The treatment at Fox Chase Cancer Center is offering new hope for patients with advanced myelofibrosis who haven't responded to standard therapies.
Want to know more?